The 2 analysts offering 12-month price forecasts for Hoth Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +99.44% increase from the last price of 5.01.
The current consensus among 2 polled investment analysts is to Buy stock in Hoth Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.